Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancersJOURNAL OF CLINICAL INVESTIGATIONIF13.62024-06-060OAAI
Off-target autophagy inhibition by SHP2 allosteric inhibitors and therapeutic implications for aberrant RAS-driven cancersCANCER RESEARCHIF16.62024-03-220PRE
Discovery of a selective TC-PTP degrader for cancer immunotherapyCHEMICAL SCIENCEIF7.42023-01-015OAAI
N-Glycosylation Facilitates 4-1BB Membrane Localization by Avoiding Its MultimerizationCELLSIF5.22022-01-048OAAI
未登录.png){kind=icon}
未登录
